Adaptin Bio (APTN) Shares Outstanding (Weighted Average) (2022 - 2026)

Adaptin Bio's Shares Outstanding (Weighted Average) history runs 5 years deep, the most recent figure standing at $2.6 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) fell 55.04% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $2.6 million (down 55.04% YoY), while the FY2025 annual figure was $2.6 million, down 19.82% from the prior year.
• Shares Outstanding (Weighted Average) came in at $2.6 million for Q1 2026 at Adaptin Bio, up from $2.6 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $5.8 million in Q1 2025 to a low of $2.6 million in Q2 2025.
• A 5-year average of $4.0 million and a median of $4.1 million in 2022 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) gained 16.54% in 2025 and tumbled 55.04% in 2026, its largest moves.
• Adaptin Bio's Shares Outstanding (Weighted Average) stood at $5.0 million in 2022, then changed by 0.0% to $5.0 million in 2023, then slumped by 35.0% to $3.2 million in 2024, then dropped by 19.82% to $2.6 million in 2025, then increased by 0.54% to $2.6 million in 2026.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $2.6 million, $2.6 million, and $2.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison